30 April 2020

Oncode Investigator Rene Bernards elected to National Academy of Sciences

Oncode Institute is proud to announce that Oncode Investigator Rene Bernards (NKI) has been elected as a member of the prestigious National Academy of Science (NAS) in the United States.

Bianca-Olivia Nita

NAS is a highly prestigious, independent scientific society. Of its 501 international members, twelve are Dutch, including Oncode Investigator Hans Clevers (Hubrecht Institute) and Anton Berns, one of the founding scientists of Oncode Institute. Rene Bernards was elected this month along 25 other international new members, in recognition of his extraordinary contributions to the study of cancer genetics.

This is not Bernards’ first membership of a renowned American scientific society. In April 2019 he was elected as member of the American Academy of Arts and Sciences (AAAS), following his April 2018 fellowship of the AACR Academy of the American Association of Cancer Research.

Other News

Oncode Coverbeeld Q2 2021
Oncode Digital Magazine - April 2021
Welcome to the April edition of our digital magazine! Discover the latest interviews, science stories, latest updates and much more.
Vesnade Jong

<span>Vesna</span><span>de Jong</span>

Vesna is a Digital Content Manager at Lygature, and is responsible for all things digital at Oncode. Originally from Slovenia, where she finished her MA in English language and literature, life led her to the Netherlands. Vesna has more than 10 years of experience in translation and localization, and has gained extensive experience of digital communications while working for one of the biggest online travel agencies.
Lude and Michiel
Oncode Investigators Michiel Vermeulen and Lude Franke receive Vici grant
Oncode is proud to announce that Oncode Investigators Michiel Vermeulen (Radboudumc) and Lude Franke (UMCG) will both receive the Vici grant of 1.5 million euros from the Dutch Research Council (NWO).
PeterThijssen
Ecto org KRT14
First patient-derived organoid model for cervical cancer
Researchers from the group of Oncode Investigator Hans Clevers (Hubrecht Institute) developed the first patient-derived organoid model for cervical cancer. They also modelled the healthy human cervix using organoids. In close collaboration with the UMC Utrecht, Princess Máxima Center for pediatric oncology and the Netherlands Cancer Institute, the researchers used the organoid-based platform to study sexually transmitted infections for a herpes virus. The model can potentially also be used to study the human papillomavirus (HPV), which is one of the main causes of cervical cancer.
Bianca-OliviaNita